Peroxisome proliferator–activated receptor γ ligands inhibit development of atherosclerosis in LDL receptor–deficient mice

The peroxisome proliferator–activated receptor γ (PPARγ) is a nuclear receptor that regulates fat-cell development and glucose homeostasis and is the molecular target of a class of insulin-sensitizing agents used for the management of type 2 diabetes mellitus. PPARγ is highly expressed in macrophage...

Descripción completa

Detalles Bibliográficos

Publicado en:	J Clin Invest
Autores principales:	Li, Andrew C., Brown, Kathleen K., Silvestre, Mercedes J., Willson, Timothy M., Palinski, Wulf, Glass, Christopher K.
Formato:	Artigo
Lenguaje:	Inglês
Publicado:	American Society for Clinical Investigation 2000
Materias:	Article
Acceso en línea:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC380255/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/10953027/ https://ncbi.nlm.nih.govhttps://doi.org/10.1172/JCI10370
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!